Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genta Incorporated
This study seeks to define the role of gallium nitrate in a specific population of patients who are expected to have received prior therapy. Preliminary clinical studies have suggested substantial evidence of antitumor activity in patients with relapsed or refractory non-Hodgkin's Lymphoma treated with gallium nitrate.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Low- or intermediate-grade NHL using the International Working Formulation, subtypes IWF A-G:
Using the Updated REAL/WHO Classification, the following pathologic subtypes are eligible:
Small lymphocytic lymphoma
Lymphoplasmacytic lymphoma/immunocytoma
Follicular lymphoma
Diffuse large B-cell lymphoma
Peripheral T-cell lymphoma, not otherwise characterized
Progression of disease following treatment with standard chemotherapy
